Biora Therapeutics, Inc. (NASDAQ:BIOR) Q2 2024 Earnings Call Transcript
Operator: Welcome to the Biora Therapeutics Second Quarter 2024 Financial Results Call. At this time, all participants are in a listen-only mode.
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | 990 | $4,966 | -19% | 0% | |
2. | 30 | $150 | -92% | 0% | |
3. | Schonfeld Strategic Advisors Ryan Tolkin (Cio) | 0 | $0 | -100% | 0% |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$0.00 | 12,506,250 | Large Shareholder | 42,362,097 | 2022-11-09 | Filing | |
$2.47 | 8,097,166 | Large Shareholder | 36,396,907 | 2021-06-14 | Filing | |
$2.47 | 8,097,166 | Large Shareholder | 36,396,907 | 2021-06-14 | Filing | |
$2.86 | 961,807 | Large Shareholder | 28,299,741 | 2021-06-01 | Filing | |
$2.86 | 306,308 | Large Shareholder | 28,299,741 | 2021-06-01 | Filing |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$0.61 | 7,517 | Director | 148,774 | 2022-07-05 | Filing |
No. | Name | Shares | Value | % Port |
---|---|---|---|---|
1. | 1,092,976.2 | $14,755,179 | 21.43% | |
2. | 260,000 | $1,524,835 | 0.21% | |
3. | 82,810 | $1,117,935 | 0% | |
4. | 50,793.5 | $685,712 | 0% | |
5. | 41,490 | $560,115 | 0% |